Social media

ICON proudly supports International Childhood Cancer Day, reaffirming our commitment to advancing research and improving outcomes for children, survivors, and families affected by childhood cancer. In the past 5 years,...

ICON is committed to bringing safe, effective, pediatric-tested treatments to children. In the past 5 years, we have participated in 423 clinical studies, including 22 malignant haematology and 18 oncology/solid tumour s...

As digital endpoints gain regulatory traction, sponsors who invest in endpoint strategy and validation today will be better positioned to run faster, more inclusive trials tomorrow. Digital health technologies are enabli...

As digital endpoints gain regulatory traction, sponsors who invest in endpoint strategy and validation today will be better positioned to run faster, more inclusive trials tomorrow. Digital health technologies are enabli...

Career progression is rarely linear, and there is no single path to leadership. In our latest blog, Sinéad McKeon discusses what drove her move from the lab bench to project management. She reflects on the capabilities...

Career progression is rarely linear, and there is no single path to leadership. In our latest blog, Sinéad McKeon discusses what drove her move from the lab bench to project management. She reflects on the capabilities...

Flow cytometry is rapidly evolving - driven by high parameter and spectral technologies, smarter data analytics and global standardisation efforts. This Spotlight hosted by Bioanalysis Zone brings together leading expe...

Flow cytometry is rapidly evolving - driven by high parameter and spectral technologies, smarter data analytics and global standardisation efforts. This Spotlight hosted by Bioanalysis Zone brings together leading expe...

ICON provides comprehensive cardiac safety monitoring supported by a team of cardiovascular electrophysiology specialists, board certified cardiologists, radiologists, and medical experts. We offer protocol consulting,...

Looking forward to #ASCPT2026. Come along to the ICON partner hub for a chat and don’t miss our Learning Lab session on 5th March at 10:30 where we will be discussing considerations for the design, safety, pharmacokineti...

Latest issue out now. Keep up to date on the most recent regulatory changes in the world of pharma, biotech and medical device clinical trials with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribe...

Latest issue out now. Keep up to date on the latest changes with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribers who have discovered the convenience of this free monthly publication by signing ...